Modern research base. Petrovax is the holder of patents for molecules and pharmaceutical manufacturing technologies in Russia and abroad.


Research center and vivarium for preclinical tests allow Petrovax to carry out a full cycle of development and implementation of medicinal products.

The company's investment program provides for the financing of advanced R&D projects.

petrovax’s development concept is based on the production of original products

The structure of R&D department allows managing the molecule inception and product lifecycle from the idea to implementation in medical practice. We involve leading Russian and foreign specialized research institutions in highly specialized studies.

areas of activities

Search for innovative molecules and conducting preclinical studies
In-depth study of the mechanism of action in terms of the pathogenesis of a corresponding disease
Proof of the safety and efficacy of drugs in preclinical studies
Development of quality control methods and manufacturing technologies
Conducting of clinical studies in accordance with GCP standards
Introduction of innovative technologies, development and optimization of manufacturing processes

in-house vivarium

Petrovax has a certified modern vivarium for preclinical studies to assess drug efficacy and safety of original medicines. Preclinical data from in-house studies form the basis for marketing authorization applications for the drugs developed by Petrovax.